Dr Ajay Goel Discusses New Methods of Testing for EOCRC, Recurrence

Ajay Goel, PhD, AGAF, explains the significance of 2 new studies that found that early-onset colorectal cancer (EOCRC) and recurrence in CRC could both be predicted using new blood and tissue tests.

Related Keywords

United States ,American ,Ajay Goel ,Department Of Molecular Diagnostics ,Molecular Diagnostics ,Experimental Therapeutics ,American Journal ,Digestive Disease ,Digestive Disease Week ,